Format

Send to

Choose Destination
See comment in PubMed Commons below
Jpn J Clin Oncol. 2013 Feb;43(2):214-6. doi: 10.1093/jjco/hys208. Epub 2012 Dec 12.

A randomized phase II trial of omentum-preserving gastrectomy for advanced gastric cancer.

Author information

1
Department of Surgery, Yokohama City University, Yokohama, Japan. hsgws@yokohama-cu.ac.jp

Abstract

This randomized Phase II trial is being conducted to evaluate the impact of omentectomy for advanced gastric cancer on patient survival. The primary endpoint is the 3-year relapse-free survival rate and the secondary endpoints are 5-year overall survival, intraoperative blood loss, length of the operation and postoperative morbidity (especially postoperative ileus). The planned sample size is 250 patients (125 for complete removal of the omentum and 125 for preservation of the omentum) to determine whether omentum-preserving gastrectomy may be a candidate procedure for a Phase III trial in a randomized Phase II setting.

PMID:
23242583
DOI:
10.1093/jjco/hys208
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems
    Loading ...
    Support Center